Cargando…
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Alzheimer’s disease is a neurological disorder that results in cognitive and behavioral impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs, often fail due to their poor solubility, lower bioavailability, and ineffective ability to cross the blood–brain barrie...
Autores principales: | Fonseca-Santos, Bruno, Gremião, Maria Palmira Daflon, Chorilli, Marlus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531021/ https://www.ncbi.nlm.nih.gov/pubmed/26345528 http://dx.doi.org/10.2147/IJN.S87148 |
Ejemplares similares
-
Design, characterization, and biological evaluation of curcumin-loaded surfactant-based systems for topical drug delivery
por: Fonseca-Santos, Bruno, et al.
Publicado: (2016) -
Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review
por: Rigon, Roberta Balansin, et al.
Publicado: (2015) -
Nanotechnology-based drug delivery systems for treatment of oral cancer: a review
por: Calixto, Giovana, et al.
Publicado: (2014) -
Hydroxyethylcellulose-Based Hydrogels Containing Liposomes Functionalized with Cell-Penetrating Peptides for Nasal Delivery of Insulin in the Treatment of Diabetes
por: Von Zuben, Eliete de Souza, et al.
Publicado: (2022) -
Bioadhesive Surfactant Systems for Methotrexate Skin Delivery
por: Cintra, Giovana Aparecida de Souza, et al.
Publicado: (2016)